Patterns of placental antimicrobial resistance in preterm birth before 30 completed weeks gestation complicated by preterm prelabour rupture of membranes

Aust N Z J Obstet Gynaecol. 2020 Aug;60(4):509-513. doi: 10.1111/ajo.13087. Epub 2019 Oct 24.

Abstract

Background: While many guidelines recommend a 10-day course of oral erythromycin following preterm prelabour rupture of membranes (PPROM) as derived from the ORACLE I trial, evidence is emerging that this may encourage a state of antenatal genital tract dysbiosis. In addition, erythromycin's lack of efficacy toward Gram-negative microorganisms may promote colonisation and infection, conveying more significant unrecognised risk for very and extremely preterm newborns.

Aims: To define patterns of placental infection or colonisation in newborns born before 30 completed weeks gestation following PPROM.

Materials and methods: Retrospective cohort study of mother-infant dyads who delivered at < 30 completed weeks gestation following PPROM in a South Australian tertiary perinatal centre between January 2012 and December 2015. Main outcome measures included placental and neonatal culture and sensitivities within 72 h of delivery and histologic chorioamnionitis. Categorical characteristics were analysed using two-sided Fisher's exact test and numerical characteristics via analysis of variance.

Results: During the four years studied, 126 infant-mother dyads were identified. Where a placental swab was taken, 23.9% cultured Gram-negative organisms and the majority (58.8%) were antimicrobial-resistant. Those that received erythromycin had increased incidence of antimicrobial-resistant Gram-negative organisms on placental swab (P = 0.02). All cases of neonatal early-onset sepsis (EOS), including two cases of multi-resistant Gram-negative EOS, occurred in those who received erythromycin.

Conclusions: The current antibiotic recommendations for PPROM may promote selection of unhindered antimicrobial-resistant Gram-negative organisms and may increase risk of Gram-negative EOS in very and extremely preterm newborns. Further wide-scale examination of antibiotic recommendations in PPROM is necessary.

Keywords: Gram-negative; antimicrobial resistance; dysbiosis; erythromycin; preterm prelabour rupture of membrane.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Australia
  • Drug Resistance, Bacterial
  • Female
  • Fetal Membranes, Premature Rupture* / drug therapy
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Outcome
  • Premature Birth* / drug therapy
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents